Teva Pharmaceutical Industries Limited (TEVA) - News Archive

Breaking New Ground in Schizophrenia Treatment: Teva Pharmaceuticals Presents Promising Long-term Safety Data from the SOLARIS Trial Teva Pharmaceuticals, a prominent player in the global pharmaceutical market and a sub...

Teva s Triple Triumph: Major Launches, Strategic Commitments, and Expanded Healthcare Access In an inspiring showcase of pharmaceutical innovation and social responsibility, Teva Pharmaceuticals has announced a series o...

In a groundbreaking presentation at Psych Congress Elevate 2025, Teva Pharmaceuticals has unveiled new data revealing significant rates of undertreated tardive dyskinesia (TD) among patients in long-term care (LTC) sett...

In a notable development for Teva Pharmaceuticals, Fitch Ratings Agency has upgraded the company s rating to BB+, acknowledging its effective pivot towards a growth strategy that has begun to bear fruit. This strategic...

: Recent developments in the pharmaceutical landscape concerning autoimmune diseases like Ulcerative Colitis (UC) and Crohn’s Disease (CD) have spotlighted Duvakitug an innovative anti-TL1A monoclonal antibody co-develo...

Date: January 29, 2025As the trading bell rang to signal the close of the market on Wednesday, January 29, 2025, investor sentiment took a hit as major equity indices retreated from the gains recorde...

Teva Pharmaceuticals’ Strategic Shift: A New Chapter with JKI and Its Implications for ShareholdersIn a pivotal move on December 5, 2024, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced a definitive...

In a significant move that underscores the ever-evolving landscape of cancer treatment, Teva Pharmaceuticals International GmbH and mAbxience have announced an expanded strategic partnership with a new global licensing...

Teva Pharmaceuticals Launches Generic Version of Sandostatin LAR Depot in the U.S. PARSIPPANY, N.J. Oct. 1, 2024 Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. has announced the launch of...

News Tel Aviv, Israel, September 23, 2024 Teva Pharmaceutical Industries Ltd. announced promising results from a recent analysis at the European College of Neuropsychopharmacology (ECNP) annual congress in Milan, reveal...

In the annals of modern pharmacotherapy, the pursuit of efficacious treatments for mental maladies remains a pressing venture, not least among them the formidable affliction of schizophrenia. It is with considerable con...